.jpg)
-
DNA Data Storage Alliance Launches With Illumina, Microsoft, Twist Bioscience, Western Digital
Dec 01 | Bio-IT World | Twist Bioscience Corporation, Illumina, and Western Digital announced an alliance last month with Microsoft to advance the field of DNA data storage. These founding companies and member organizations will work together to create a comprehensive industry roadmap that will help the industry achieve interoperability between solutions and help establish the foundations for a cost-effective commercial archival storage ecosystem for the explosive growth of digital data. More -
Power of AI With Cloud Computing is “Stunning” to Microsoft’s Nadella
Nov 30 | Bio-IT World | Microsoft CEO Satya Nadella said at the AI and the Future of Work Conference from MIT that cloud computing today is massively powerful. More -
BERG, AdventHealth Use AI to Scan Patient Records, Improve Outcomes
Nov 24 | Bio-IT World | What started as a collaboration to study non-alcoholic fatty liver disease is shifting gears to tackle COVID-19. BERG and AdventHealth are partnering to apply AI to enhance COVID-19 patient care by rapidly identifying the right path to improve patient outcomes. More -
AI, Hybrid Cloud and Quantum Computing Seen by IBMs Krishna as Shaping IT
Nov 23 | Bio-IT World | IBM CEO Arvind Krishna sees AI, hybrid cloud computing, and quantum computing as setting the future of the IT industry. More -
New Virtual Reality Tool, Domestic Cats are SARS-CoV-2 Carriers, Combination Therapy Advances: COVID-19 Updates
Nov 20 | Bio-IT World I St. Jude discovers hyperinflammatory pathway, hepatitis C drugs are potential treatment, non-human primate model identifies features of virus, IL-10 production is a marker for severity, recommendations on re-use of data, molecular structure of key E-protein, and early antibody evolution predicts outcomes. Plus: Disrupting SKI complex prevents viral replication, why COVID-19 spares children, and how smoking causes more severe infection. More -
Behind the VC Curtain: Investors Talk About Post-COVID Trends and the ‘New’ Healthcare Tech
Nov 19 | Bio-IT World | COVID-19 is switching the risk paradigm for biotech and pharma. It’s too risky, now, not to do something digital. It’s driving changes in investing as well. A recent panel discussion explored how venture capital and new tech companies evaluate technology, invest cash, and plan to move forward. More -
Molecular Tagging System With Real-World Potential
Nov 17 | Bio-IT World | A decades-old technology initially used to hide secret messages in dots of DNA—along with Oxford Nanopore sequencing—could get a reboot as a tracking system for commodities that might be too small or numerous for tagging with QR codes or radio-frequency identification, such as experimental drugs and controlled substances. More -
Illumina Announces P3 High-Output Flow Cell, NextSeq 1000
Nov 13 | Bio-IT World | Illumina has announced the commercial availability of the P3 high-output flow cell, offering 1.1 billion reads in a single sequencing run. The company also announced the commercial availability of the NextSeq 1000. More -
New Rhesus Macaque Model, Six SARS-CoV-2 Strains, the Structure of Dexamethasone with Serum Albumin: COVID-19 Updates
Nov 13 | Bio-IT World | A look at how COVID-19 patients fare after recovery, Mount Sinai’s new ML model analyzes EHRs, overlapping genes in viruses, conferred immunity from other coronaviruses, and a picture of RNA-RNA interactions. Plus a new Intel system at LLNL for COVID-19 research, Baylor’s coronavirus curriculum, and a recommended vaccine distribution framework. More -
Big Data, Supercomputing Deployed For Disease Risk Prediction Models
Nov 12 | Bio-IT World | The Department of Veterans Affairs (VA) and the Department of Energy (DOE) have teamed up to develop disease risk prediction models using deep learning, according to Ravi Madduri, a computer scientist at the DOE’s Argonne National Laboratory and co-lead of the collaboration. More
Riffyn’s pioneering cloud system, Riffyn Nexus, delivers 2X faster development cycles and 4X productivity gains to the world’s most advanced scientific R&D organizations. Its process-centric experiment design, data capture, and
data analytics overcome the limitations of ELN and LIMS systems. Its adaptive data integration engine delivers results that are always ready for machine learning.
Read more here!
Digital Therapeutics: Taking digital health to a new level
Benchling is the most widely-adopted life sciences R&D cloud. Accelerate, measure, and forecast R&D – from discovery through bioprocessing – all
in one place. It’s a fully unified platform that centralizes and standardizes all R&D data, so you can spend less time fighting with legacy software, and more time reaching breakthrough discoveries.
Read more here!
